Ann J. Johanson
#117,967
Most Influential Person Now
American pediatric endocrinologist
Ann J. Johanson's AcademicInfluence.com Rankings
Ann J. Johansonphilosophy Degrees
Philosophy
#11816
World Rank
#16333
Historical Rank
#2272
USA Rank
Logic
#8628
World Rank
#10820
Historical Rank
#1441
USA Rank
Download Badge
Philosophy
Ann J. Johanson's Degrees
- Doctorate Medicine Harvard University
- PhD Endocrinology Stanford University
Why Is Ann J. Johanson Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ann J. Johanson was an American pediatric endocrinologist. She was a professor at the University of Virginia School of Medicine. At UVA, she was the founding director of the Division of Pediatric Endocrinology. In 1971, she and her colleague Robert M. Blizzard first described Johanson-Blizzard Syndrome.
Ann J. Johanson's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. (1982) (348)
- Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. (1998) (254)
- Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group. (1997) (210)
- A syndrome of congenital aplasia of the alae nasi, deafness, hypothyroidism, dwarfism, absent permanent teeth, and malabsorption. (1971) (157)
- Effect of testosterone on somatomedin-C concentrations in prepubertal boys. (1984) (139)
- Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. (1993) (125)
- Three-year results of a randomized prospective trial of methionyl human growth hormone and oxandrolone in Turner syndrome. (1988) (121)
- Integrated concentration and circadian variation of plasma testosterone in normal men. (1973) (120)
- Factors predicting the response to growth hormone (GH) therapy in prepubertal children with GH deficiency. (1993) (104)
- Growth hormone treatment in the United States: demographic and diagnostic features of 2331 children. (1990) (98)
- Carbohydrate and lipid metabolism in Turner syndrome: effect of therapy with growth hormone, oxandrolone, and a combination of both. (1988) (92)
- Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. (1996) (80)
- Methionyl human growth hormone and oxandrolone in Turner syndrome: preliminary results of a prospective randomized trial. (1986) (79)
- Lack of increased risk for extracranial, nonleukemic neoplasms in recipients of recombinant deoxyribonucleic acid growth hormone. (1995) (78)
- Outcome of a four-year randomized study of daily versus three times weekly somatropin treatment in prepubertal naive growth hormone-deficient children. Genentech Study Group. (1996) (76)
- Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature. (1984) (74)
- Correlation of serum follicular stimulating hormone (FSH) and luteinizing hormone (LH) as measured by radioimmunoassay in disorders of sexual development. (1970) (69)
- Long‐Term Follow‐Up of Hypopituitary Patients Treated with Human Growth Hormone (1990) (62)
- Idiopathic short stature: results of a one-year controlled study of human growth hormone treatment. Genentech Collaborative Study Group. (1989) (59)
- Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone. (1983) (58)
- Serum luteinizing hormone by radioimmunoassay in normal children. (1969) (52)
- Long-term effects of vasectomy on pituitary-gonadal function in man. (1975) (51)
- Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma. (1975) (45)
- Measurement of immunologically reactive follicle stimulating hormone in serum of normal male children and adults. (1969) (43)
- The effects of ovine prolactin on water and electrolyte excretion in man are attributable to vasopressin contamination. (1977) (42)
- Psychosocial Impact of Long-Term Growth Hormone Therapy (1986) (38)
- Elucidation of normal ovarian physiology by exogenous gondaotropin stimulation following steroid pituitary suppression. (1969) (34)
- BLOOD PRESSURE AND PUBERTY (1974) (33)
- Congenital lipodystrophy: An endocrine study in three siblings. I. Disorders of carbohydrate metabolism. (1978) (33)
- Urinary excretion of radioimmunoassayable luteinizing hormone (LH) in normal male children and adults, according to age and stage of sexual development. (1970) (32)
- Diagnostic Significance of Urinary Growth Hormone Measurements in Children with Growth Failure: Correlation between Serum and Urine Growth Hormone (1991) (31)
- Growth in patients with gonadal dysgenesis receiving fluoxymesterone. (1969) (31)
- Silver-Russell syndrome and craniopharyngioma. (1980) (30)
- Emulsion Polymerization of Myrcene (1948) (29)
- Involvement of the thyroid gland in histiocytosis X. (1981) (29)
- Results from the First 2 Years of a Clinical Trial with Recombinant DNA‐derived Human Growth Hormone (Somatrem) in Turner's Syndrome (1987) (28)
- Treatment of congenital virilizing adrenal hyperplasia patients with single and multiple daily doses of prednisone. (1977) (27)
- The Lenz-Majewski hyperostotic dwarfism. A syndrome of multiple congenital anomalies, mental retardation, and progressive skeletal sclerosis. (1977) (26)
- Excretion of Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH) in Urine by Pubertal Girls (1972) (26)
- Fluctuations of gonadotropin levels in children. (1974) (25)
- Growth-hormone-releasing factor. (1983) (24)
- Growth hormone for short stature not due to classic growth hormone deficiency. (1990) (24)
- A Retrospective Evaluation of Psychosocial impact of Long-term Growth Hormone Therapy (1986) (22)
- Low somatomedin-C levels in older men rise in response to growth hormone administration. (1981) (22)
- Determination of Serum Luteinizing Hormone (SLH) by Radioimmunoassay in Disorders of Adolescent Sexual Development (1969) (21)
- Congenital lipodystrophy. II. Association with polycystic ovarian disease. (1979) (20)
- Special Female Hermaphroditism Associated with Multiple Disorders (1972) (20)
- Growth hormone therapy in Turner's syndrome: An update on final height (1992) (19)
- Immunoreactive luteinizing hormone in acetone precipitates and kaolin extracts of human urine. (1970) (18)
- Hypomagnesemia due to renal tubular defect in reabsorption of magnesium. (1974) (18)
- Growth hormone deficiency in anorexia nervosa. (1975) (17)
- TREATMENT OF ANOREXIA NERVOSA BY LEVODOPA (1974) (17)
- Response to growth hormone in children with idiopathic short stature. (1990) (15)
- The renin-aldosterone system in cystic fibrosis. (1981) (13)
- Sulfanilamide Derivatives. I (1939) (12)
- A single growth hormone determination to rule out growth hormone deficiency. (1977) (11)
- Cerebral gigantism and thyrotoxicosis. (1980) (11)
- 102 PROSPECTIVE, RANDOMIZED TRIAL OF METHIOMYL HUMAN GROWTH HORMONE AND/OR OXANDROLONE IN TURNER SYNDROME (1985) (10)
- Critical Body Weight in Anorexia Nervosa (1974) (9)
- Treatment of Turner's Syndrome with Recombinant Human Growth Hormone (Somatrem) (1988) (9)
- Gonadal dysgenesis with 45,XO/46,XX mosaicism demonstrated only in a streak gonad. (1977) (8)
- Isodicentric X chromosome in a girl with gonadal dysgenesis. (1983) (5)
- GROWTH HORMONE THERAPY IN TURNER'S SYNDROME (1988) (4)
- H-Y intermediate phenotype in male pseudohermaphroditism. (1986) (4)
- A NEWLY DEFINED HYPEROSTOTIC DWARFING SYNDROME (1977) (4)
- Somatostatin lowering of LH levels in a postmenopausal woman. (1977) (3)
- Urinary Growth Hormone and Insulin-like Growth Factor I (1992) (2)
- Achievement and behavioral problems in short children starting growth hormone gh treatment varies by medical diagnosis (1991) (2)
- Emulsifiers for GR-S from Resin Acid Derivatives (1949) (2)
- A comparison of the effects of insulin and pyrogen as stimuli to growth hormone release in man. (1968) (2)
- Emulsion Copolymerization of Isoprene and Styrene (1948) (2)
- GH TREATMENT IN IDIOPATHIC SHORT STATURE: INFLUENCE OF PUBERTY AND SEX ON SKELETAL MATURATION AND GROWTH RESPONSE (1994) (1)
- Somatotroph hyperplasia: successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. (1982) (1)
- Letter: Treatment of anorexia nervosa by levodopa. (1974) (1)
- Development of Gas-Insulated Compact Capacitor Banks (1979) (1)
- Long-term effects of vasectomy on pituitary-gonadal function in man. (1975) (0)
- Congenital lipodystrophy: in three siblings An endocrine study (1978) (0)
- Effect of prolactin on human renal function (1976) (0)
- Treatment of pseudohypoparathyroidism with oral vitamin D biweekly. (1977) (0)
- Dose Studies for Human Growth Hormone in Hypopituitarism (1986) (0)
- H-Y Intermediate Phenotype in Male Pseudohermaphroditism (1987) (0)
- 27 Growth Hormone-Releasing Factor (1986) (0)
- GROWTH HORMONE (GH) RELEASE IN CHILDREN WITH SHORT STATURE: STIMULATION BY HUMAN PANCREATIC TUMOR GROWH HORMONE RELEASING FACTOR-40 (hpGRF-40) (1984) (0)
- Editorial: Critical body weight in anorexia nervosa. (1974) (0)
- Short Children and Growth Hormone (1984) (0)
- EFFICACY OF AN ANTIHISTAMINE/DECONGESTANI IN TREATMENT OF OTITIS MEDIA (1974) (0)
- Serum insulin levels in untreated juvenile diabetes mellitus (1965) (0)
- Serum luteinizing radioi m m u noassa y hormone by in normal children (1969) (0)
- SKELETAL MATURATION AND GROWTH DURING PUBERTY IN PATIKNTS WITH GROWTH HORMONE (GH) DEFICIENCY OR IDIOPATIHC SHORT STATURE TREATED WITH GH (1993) (0)
This paper list is powered by the following services:
Other Resources About Ann J. Johanson
What Schools Are Affiliated With Ann J. Johanson?
Ann J. Johanson is affiliated with the following schools:
